Federal Drug Crimes Defense: A Federal Defense Lawyer’s Guide

By Elizabeth Franklin-Best, Esq., and Christopher Zoukis, JD, MBA

Federal drug cases are defined by one feature above all others: mandatory minimum sentences that can put years — sometimes decades — on the table before a judge ever exercises discretion. Because the charging decision itself can fix the sentencing floor, the time to involve a federal drug crime lawyer is before that decision is made, while quantity, charge selection, and cooperation posture are still in play. At Elizabeth Franklin-Best, P.C., we defend individuals against federal drug charges nationwide.

Federal drug crimes are prosecuted under the Controlled Substances Act — trafficking, conspiracy, possession with intent to distribute, the continuing criminal enterprise “kingpin” statute, and prescription diversion. Drug type and quantity drive the penalties, and conspiracy law allows the government to hold a defendant responsible for far more than they personally handled.

In drug cases, our defense work starts from the statute and the record: the quantity the government claims, the legality of every stop and search, the strength of its conspiracy theory, and each statutory route below the minimum. Elizabeth Franklin-Best, our principal attorney, carries a 2026 Best Lawyers in America recognition as a “Best Lawyer” in Appellate Practice, and Chambers USA ranks the firm in its 2026 guide for Litigation: White-Collar Crime & Government Investigations. Much of the leverage in a drug case is won at sentencing, and that is terrain our principal attorney works constantly: she has handled more than 330 federal proceedings — over 100 of them appeals across all twelve circuits — and maintains an active practice in safety-valve eligibility, Amendment 821 criminal-history recalculation, and First Step Act § 404 resentencings, the very mechanisms that decide how a drug sentence comes out. If a federal drug investigation or indictment has reached you, we invite you to schedule a paid, one-hour initial consultation with our team.

Federal Drug Crimes: Quick Answer

Question	Answer
What are federal drug crimes?	Offenses under the Controlled Substances Act — trafficking, conspiracy, possession with intent, continuing criminal enterprise, and prescription diversion.
What drives the penalties?	Drug type and quantity. Threshold amounts trigger 5-year and 10-year mandatory minimum sentences.
What must the government prove?	That the defendant knowingly possessed or distributed a controlled substance — and, for the enhanced penalties, the type and quantity involved.
Can I get below a mandatory minimum?	Sometimes — through the safety valve, substantial-assistance motions, or by defeating the quantity the government must prove.
How do we begin?	With a paid, one-hour initial consultation reviewing the charges, the quantity allegations, and every realistic path below a mandatory minimum.

Key Takeaways

• Federal drug crimes are prosecuted under the Controlled Substances Act, principally 21 U.S.C. §§ 841, 846, and 848.
• Drug type and quantity drive the penalties — threshold amounts trigger 5-year and 10-year mandatory minimum sentences.
• The base offense requires only that the defendant knowingly possessed or distributed a controlled substance; quantity, not the base crime, drives the penalty.
• Drug conspiracy under § 846 requires no overt act — the agreement itself is the crime.
• Conspiracy law can attribute to a defendant drug quantities handled by others in the conspiracy.
• The continuing criminal enterprise “kingpin” statute carries a 20-year mandatory minimum and can reach life.
• The Fourth Amendment is central — many drug cases turn on the legality of a stop, search, or seizure.
• The safety valve and substantial-assistance motions are the principal routes below a mandatory minimum.
• Under Alleyne v. United States, any drug type or quantity that raises a mandatory minimum must be charged in the indictment and found by a jury beyond a reasonable doubt.
• The HALT Fentanyl Act of 2025 permanently placed fentanyl-related substances in Schedule I and extended the quantity-based mandatory minimums to them.

What Are Federal Drug Crimes?

Federal drug crimes are offenses under the Controlled Substances Act, the federal statute that classifies controlled substances and criminalizes their manufacture, distribution, and possession. While most drug cases in the United States are prosecuted in state court, the federal government takes on cases involving larger quantities, interstate or international movement, organized distribution networks, firearms, and — increasingly — prescription drug diversion.

What sets federal drug prosecution apart is its sentencing structure. Federal drug law is built around mandatory minimum sentences tied to the type and quantity of the controlled substance. Reach a threshold quantity, and a five-year or ten-year minimum attaches — a floor the sentencing judge generally cannot go below except through specific, narrow mechanisms. That structure makes federal drug defense, more than almost any other area, a fight over quantity, over the legality of the government’s evidence, and over the routes around a mandatory minimum.

The federal drug offenses our firm defends are explained in depth in the guides below — and a single case often involves several of them simultaneously.

The Federal Drug Crime Statutes

• Federal Drug Trafficking Defense (21 U.S.C. § 841) — the core trafficking statute covering manufacture, distribution, and possession with intent to distribute.
• Federal Drug Conspiracy Defense (21 U.S.C. § 846) — the conspiracy statute, which carries the same penalties as the underlying offense and requires no overt act.
• Possession with Intent to Distribute Defense — the PWID offense, and the fight over whether possession was for distribution or personal use.
• Federal Marijuana Charges Defense — trafficking, cultivation, and distribution of marijuana, which remains a Schedule I controlled substance federally despite state legalization.
• Continuing Criminal Enterprise Defense (21 U.S.C. § 848) — the “kingpin” statute aimed at the organizers of large drug operations.
• Prescription Drug Diversion Defense — the prosecution of physicians, pharmacists, and others for diverting prescription controlled substances.
• Drug Importation & Smuggling Defense (21 U.S.C. §§ 952 & 960) — bringing a controlled substance across the border, charged in border-seizure and international-shipment cases. The § 960 penalty tiers mirror the § 841(b) thresholds quantity for quantity, so an importation count carries the same five- and ten-year mandatory minimums as a domestic trafficking count.

Drug cases also frequently carry federal firearms counts — most consequentially under 18 U.S.C. § 924(c), which adds a consecutive mandatory term for a firearm possessed in furtherance of drug trafficking — along with money laundering counts and forfeiture exposure, connecting them to our broader federal criminal defense practice.

Drug Type and Quantity: The Heart of the Case

In a federal drug case, the base offense and the penalty are two separate questions, and understanding the difference is essential.

The base offense under § 841(a) is straightforward: knowingly or intentionally manufacturing, distributing, or possessing with intent to distribute a controlled substance. The statute defining the offense says nothing about quantity — possession with intent to distribute any measurable amount violates it.

Quantity enters through the penalty provisions of § 841(b). Those provisions create a tiered structure: specified threshold quantities of each drug trigger a five-year mandatory minimum; larger thresholds trigger a ten-year mandatory minimum; and prior convictions and certain aggravating factors push the minimums higher still. Because quantity drives the sentence so powerfully, the quantity attributed to the defendant is the single most contested issue in most federal drug cases. Challenging the government’s drug-weight evidence, its lab analysis, its extrapolations, and its conspiracy-wide attribution can move a case across mandatory-minimum lines and change a sentence by years.

These thresholds are not mere sentencing factors. Under Alleyne v. United States, 570 U.S. 99 (2013), any fact that raises a mandatory minimum is an element of the offense — it must be charged in the indictment, submitted to the jury, and found beyond a reasonable doubt. The government cannot reach the five- or ten-year floors of 21 U.S.C. § 841(b) on a judge’s preponderance finding alone; the drug type and the threshold quantity must survive the full rigor of trial proof. That constitutional rule gives the defense genuine leverage at trial and in plea negotiations alike.

Applied Insight: Drug quantity is not a fixed fact handed down from on high — it is an evidentiary proposition the government must prove. Lab weights, the inclusion or exclusion of mixtures and dilutants, extrapolation from samples, and the amounts attributed through conspiracy all involve assumptions a defense can test. A successful quantity challenge can collapse a mandatory minimum entirely.

Conspiracy and Attributed Quantity

One of the most important — and most dangerous — features of federal drug law is how conspiracy and “relevant conduct” can expand a defendant’s exposure.

Under the conspiracy statute, § 846, a defendant who agreed to participate in a drug distribution conspiracy can be held responsible not only for the drugs they personally touched, but for the quantities handled by others in the conspiracy — to the extent those quantities were within the scope of the agreement the defendant joined and were reasonably foreseeable to them. A minor participant can find themselves facing a mandatory minimum driven by the entire organization’s drug volume.

This makes two defense tasks critical. The first is contesting the existence and scope of the conspiracy itself — distinguishing a genuine agreement to distribute from a mere buyer-seller relationship, which is not a conspiracy. The second is fighting the attribution of quantity — insisting that a defendant be held responsible only for what was within the scope of their own agreement and reasonably foreseeable to them, not for the organization’s total volume. Both fights can dramatically reduce exposure.

The Fourth Amendment in Drug Cases

Federal drug cases are, more than almost any other category, search-and-seizure cases. The government’s evidence — the drugs, the cash, the phones, the records — usually comes from a stop, a search, or a seizure, and the Fourth Amendment governs every one of them.

A traffic stop without lawful justification, a search that exceeded its lawful scope, a warrant unsupported by probable cause, a prolonged detention, a coerced or invalid consent, an unlawful use of a drug dog, or a defective wiretap can all render the government’s central evidence inadmissible. A successful motion to suppress can gut a drug prosecution — sometimes ending it. That is why a careful drug defense scrutinizes the constitutionality of how every piece of the government’s evidence was obtained.

Applied Insight: In a drug case, the suppression motion is often the whole case. When the controlled substance itself is the product of an unlawful search, excluding it can leave the government with nothing to prove. The earliest and most important defense work is frequently a rigorous review of every stop, search, warrant, and wiretap in the file.

Mandatory Minimums and the Routes Around Them

Because mandatory minimums dominate federal drug sentencing, the routes around them are central to the defense.

• Defeating the quantity. The most direct route — if the government cannot prove a threshold quantity, the mandatory minimum does not attach.
• The safety valve. A statutory provision that allows a sentence below the mandatory minimum for defendants who meet specific criteria, including a limited criminal history, no violence or weapon, no leadership role, and full and truthful disclosure to the government.
• Substantial assistance. Where a defendant provides substantial assistance to the government, a prosecution motion can permit a sentence below the mandatory minimum.
• Challenging prior-conviction enhancements. Enhanced minimums based on prior convictions can sometimes be contested.

Each of these requires careful, informed handling, and the safety valve in particular has detailed criteria that must be navigated with counsel. Identifying every available route below a mandatory minimum, early, is a defining task of federal drug defense.

The Safety Valve After Pulsifer

The safety valve, codified at 18 U.S.C. § 3553(f), is the only mechanism that lets a judge sentence below a drug mandatory minimum without a government motion. A defendant qualifies only by satisfying every one of five criteria: a limited criminal history; no violence, credible threats, or possession of a dangerous weapon in connection with the offense; no death or serious bodily injury resulting from the offense; no organizer, leader, manager, or supervisor role and no continuing criminal enterprise; and a complete, truthful disclosure to the government of everything the defendant knows about the offense before sentencing.

The First Step Act of 2018 widened the criminal-history gateway, and the Supreme Court defined its outer limit in Pulsifer v. United States, 601 U.S. 124 (2024). The statute disqualifies a defendant with more than four criminal history points (excluding one-point offenses), a prior three-point offense, or a prior two-point violent offense — and Pulsifer held that this list operates as a checklist, not a package. Failing any single condition forecloses eligibility; a defendant does not need to fail all three. After Pulsifer, the precise arithmetic of a client’s criminal history score can be worth five or ten years, which makes auditing the presentence report’s point calculations — including the status-point changes made by Guidelines Amendment 821 — essential safety-valve work.

Two practical points are easy to miss. First, the disclosure requirement is not cooperation: the defendant must tell the government everything truthfully, but the information does not have to prove useful, and no substantial-assistance motion is required. Second, meeting the safety-valve criteria also earns a two-level reduction in the offense level under the drug Guidelines — a benefit that matters even in cases where no mandatory minimum applies. We treat safety-valve eligibility as a sentencing project that begins the day we enter a case, not a box checked at the end.

Penalties for Federal Drug Crimes

Federal drug penalties are severe and quantity-driven. Depending on the drug type and amount, a trafficking or conspiracy conviction can carry a five-year mandatory minimum (up to 40 years), a ten-year mandatory minimum (up to life), or — for the largest quantities combined with prior convictions or a death or serious bodily injury — even higher minimums. The continuing criminal enterprise statute carries its own 20-year mandatory minimum and can carry a life sentence. Substantial fines, supervised release, and forfeiture also apply.

The statute ties its two principal floors to specific drug weights. The table below shows the threshold quantities that trigger the five-year minimum under § 841(b)(1)(B) and the ten-year minimum under § 841(b)(1)(A) for the most commonly charged substances:

Substance	5-Year Minimum (§ 841(b)(1)(B))	10-Year Minimum (§ 841(b)(1)(A))
Heroin	100 grams	1 kilogram
Cocaine (powder)	500 grams	5 kilograms
Cocaine base (crack)	28 grams	280 grams
Methamphetamine	5 grams (actual) / 50 grams (mixture)	50 grams (actual) / 500 grams (mixture)
Fentanyl	40 grams	400 grams
Fentanyl analogues and fentanyl-related substances	10 grams	100 grams
Marijuana	100 kilograms or 100 plants	1,000 kilograms or 1,000 plants

Aggravators move these floors higher. A prior conviction for a serious drug felony or serious violent felony raises the ten-year minimum to fifteen years (and a second such prior raises it to twenty-five), but only if the government files a timely information under 21 U.S.C. § 851 — a procedural step the defense should always scrutinize. And if death or serious bodily injury results from use of the substance, the minimum under either tier jumps to twenty years. That “death results” enhancement is not loosely applied: in Burrage v. United States, 571 U.S. 204 (2014), the Supreme Court held that the government must prove the drug the defendant distributed was a but-for cause of the death — that the death would not have occurred without it — and, because the enhancement raises the statutory penalty range, it is an element a jury must find beyond a reasonable doubt. In the mixed-drug-toxicity cases that fill federal overdose dockets, Burrage causation is frequently the decisive issue. Each enhancement has its own proof requirements, and each can be contested.

Above the mandatory minimum, the advisory United States Sentencing Guidelines drive the sentence, and in drug cases, the Guidelines are also quantity-driven. The drug weight, the defendant’s role, the presence of a firearm, and prior history all shape the range. Because both the statutory minimums and the Guidelines turn on quantity, a disciplined challenge to the drug weight is the most consequential sentencing work in nearly every federal drug case.

What Changed in Federal Drug Law (2022–2026)

Federal drug practice has moved considerably in the past few years, and several of the changes cut in a defendant’s favor. The developments below now shape how we evaluate every new drug case:

• Ruan v. United States, 597 U.S. 450 (2022). In prosecutions of physicians, pharmacists, and other licensed practitioners under § 841, once the defendant produces evidence that the prescribing was authorized, the government must prove beyond a reasonable doubt that the practitioner knowingly or intentionally acted in an unauthorized manner. The Court rejected the objective “good faith” and “honest effort” standards some circuits had used — a subjective mens rea now governs prescription drug diversion cases.
• Pulsifer v. United States, 601 U.S. 124 (2024). The Supreme Court read the safety valve’s criminal-history requirement as a checklist — failing any one of its conditions disqualifies a defendant — which is discussed in detail in the safety-valve section above.
• Guidelines Amendment 821 (November 1, 2023, retroactive). The Sentencing Commission cut “status points” for offenses committed under supervision and created a two-level reduction for zero-point offenders. Both changes apply retroactively through 18 U.S.C. § 3582(c)(2), and both can alter safety-valve arithmetic and drug Guidelines ranges.
• Guidelines Amendment 826 (November 1, 2024). Conduct on which a jury acquitted a defendant no longer counts in calculating the Guidelines range — a meaningful shift in drug cases, where juries sometimes convict on one count while rejecting others or finding lower quantities.
• The 2025 Guidelines simplification package (November 1, 2025). The Commission removed the departure step from the sentencing process and eliminated most personal-characteristic departure provisions, so mitigation in drug cases now travels almost entirely through variance arguments under 18 U.S.C. § 3553(a).

Each of these developments creates concrete work in a pending case: re-running criminal history under Amendment 821, isolating acquitted conduct from the quantity calculation, framing mitigation as variance rather than departure, and — in practitioner cases — holding the government to Ruan’s subjective-intent standard.

Fentanyl-Related Substances and the HALT Fentanyl Act

Fentanyl prosecutions now dominate federal drug dockets, and the legal status of fentanyl’s chemical cousins changed definitively in 2025. Fentanyl itself remains a Schedule II drug with accepted medical uses. But “fentanyl-related substances” — a structurally defined class covering thousands of possible compounds — had been controlled only by a temporary DEA scheduling order issued in 2018 and repeatedly extended by Congress.

The HALT Fentanyl Act, signed into law in July 2025, made that temporary regime permanent. The Act places fentanyl-related substances as a class in Schedule I and expressly extends the quantity-based mandatory minimums of § 841 and the parallel importation penalties of 21 U.S.C. § 960 to offenses involving them. The thresholds for fentanyl analogues are dramatically lower than for other drugs: ten grams triggers the five-year minimum, and one hundred grams triggers the ten-year minimum.

For the defense, the chemistry is now the case. Which compound the substance actually is, whether the laboratory identified it correctly, how a mixture’s weight was measured, and whether the government can prove the defendant knew they were dealing with a controlled substance at all are each litigable questions — and in counterfeit-pill prosecutions, where defendants often claim they believed the pills were something else, the knowledge element deserves particular attention.

Cartel Designations and the 2025–2026 Enforcement Shift

Federal drug enforcement priorities shifted sharply in 2025. Early that year, the Executive Branch designated several major drug-trafficking organizations — including the Sinaloa Cartel and Cartel Jalisco Nueva Generación — as foreign terrorist organizations and specially designated global terrorists. The Department of Justice has since directed substantial resources toward cartel-linked prosecutions and has begun pairing traditional drug charges with terrorism-based counts.

In practice, that means indictments in supply-chain cases increasingly add narco-terrorism charges under 21 U.S.C. § 960a and material-support charges under 18 U.S.C. § 2339B alongside familiar § 841 and § 846 counts. These statutes carry severe penalties and consecutive exposure, and the government has used them against alleged distributors and money movers well below cartel leadership.

The defense implications are significant. Terrorism-labeled counts raise the stakes at detention hearings, complicate discovery, and carry potential sentencing enhancements — but they also add elements the government must actually prove, including the defendant’s knowledge of the organization’s designation or terrorist activity. An individual swept into a conspiracy indictment two or three levels removed from any cartel is entitled to hold the government to every one of those elements, and we examine terrorism-adjacent counts with the same element-by-element rigor we apply to the drug counts themselves.

Defenses to Federal Drug Charges

No two drug cases are alike, and no lawyer can promise a result. But several defense themes recur, and matching them to the evidence is the core of building a strategy:

• Fourth Amendment violations. An unlawful stop, search, seizure, warrant, or wiretap can render the government’s central evidence inadmissible.
• Lack of knowledge or possession. The defendant did not knowingly possess the controlled substance, nor did they have the dominion and control that possession requires.
• Quantity challenges. The government cannot prove the threshold drug quantity that triggers the mandatory minimum or sets the Guidelines range.
• No conspiracy. The evidence shows a mere buyer-seller relationship, not an agreement to join a distribution conspiracy.
• Overstated attribution. A defendant should be held responsible only for quantities within the scope of their own agreement and reasonably foreseeable to them.
• Personal use, not distribution. The evidence does not establish an intent to distribute.
• Mandatory-minimum relief. The safety valve, substantial assistance, and challenges to prior-conviction enhancements.
• Entrapment. In undercover or informant cases, the government may have induced the defendant to commit an offense they would not otherwise have committed.

The right combination depends entirely on the facts. Our role is to test the government’s proof element by element, develop a favorable record, and press every legitimate defense during the investigation, in pretrial motions, at trial, and on appeal.

Why Work With Elizabeth Franklin-Best, P.C.?

Federal drug cases reward defense lawyers who attack quantity, who litigate the Fourth Amendment hard, who understand how conspiracy attribution works, and who know every route around a mandatory minimum. That is the practice we bring to every drug case.

Elizabeth Franklin-Best, our principal attorney, wrote Reversing Your Criminal Conviction and is admitted to the United States Supreme Court and all twelve federal circuit courts of appeals, with district-court admissions and pro hac vice appearances that let us take drug cases anywhere in the country. Her record runs deep where drug cases are usually won or lost — at sentencing and on review: she served as counsel in the South Carolina resentencing landmark Aiken v. Byars and has litigated complex federal mitigation and post-conviction matters that demand fluent command of the relevant-conduct, role, and § 3553(a) analysis that drives every drug Guidelines calculation. Christopher Zoukis, our Managing Director, concentrates on federal sentencing and Bureau of Prisons issues — the questions that determine where, and for how long, a drug sentence is actually served. Together, we defend clients from the first investigative contact through trial, sentencing, and appeal.

No defense firm can guarantee how a drug case ends, and we will never pretend otherwise. What we offer is disciplined, element-by-element defense work: the quantity audited, the searches tested, the conspiracy theory pressed, and every statutory exit from a mandatory minimum developed in time to matter. To put that approach to work on your case, schedule a paid, one-hour initial consultation.

Talk With a Federal Drug Crime Lawyer

Mandatory minimums reward early action: quantity allegations harden quickly, § 851 filing decisions get made, and safety-valve eligibility can turn on steps taken in the first weeks of a case. If federal agents or prosecutors have focused on you, talk with a federal drug crime lawyer before the government’s choices narrow yours. Schedule your paid, one-hour initial consultation with our team today.